Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RECOVER-SLEEP
NCT06404099Phase 2Completed
- Sponsor
- Duke University
- Start
- Aug 2024
- Primary completion
- Mar 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of modafinil, solriamfetol in post-COVID-19 condition (PCC), Hypersomnia (HS), sponsored by Duke University. Started Aug 2024; status: completed.
02
Drugs
modafinilsolriamfetol
03
Conditions
post-COVID-19 condition (PCC)Hypersomnia (HS)
Beyond the preview
Go deeper on NCT06404099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06404099.